Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion
NCT02087345 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-03-30
Summary
Dental erosions, the chemical dissolution of enamel without bacterial involvement, are considered to be an established complication of gastroesophageal reflux disease (GERD) by the Montreal global consensus statement. Given the high prevalence of dental erosions and the absence of any pH-impedance data or medical management guidelines for GERD-associated dental erosions, reflux characteristics will be characterized using questionnaires, endoscopy and esophageal pH-impedance testing, in successive patients dental erosions referred by dentists for evaluation of GERD. For assessment of the role of additional factors besides H+ activity in the refluxate, a sample of gastric juice will be aspirated during endoscopy and frozen for analysis of pepsin and other proteases. Prognostic factors for progression of dental erosions will be determined by repeating the evaluation after chronic dosing with esomeprazole 20mg twice-daily, which is prescribed to all patients.
Conditions
- Dental Erosion
- Gastroesophageal Reflux
Sponsors & Collaborators
-
Brain-Gut Research Group
lead OTHER
Principal Investigators
-
Clive Wilder-Smith, MD · Brain-Gut Reserach Group
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-15
- Primary Completion
- 2022-12-31
- Completion
- 2023-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
NCT01167543 ·Status: COMPLETED
-
Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection
NCT02788591 ·Status: TERMINATED ·Phase: NA
-
Epithelial Damage in GERD
NCT01867931 ·Status: COMPLETED
-
Association Between Gastroesophageal Reflux Disease (GERD) Severity and Dental Caries
NCT07108751 ·Status: COMPLETED
-
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06778824 ·Status: RECRUITING ·Phase: NA
-
Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients
NCT01742377 ·Status: COMPLETED
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
NCT03436914 ·Status: COMPLETED ·Phase: NA
-
Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication
NCT02934152 ·Status: UNKNOWN ·Phase: PHASE4
-
GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals
NCT02584751 ·Status: UNKNOWN ·Phase: PHASE1
-
PPI Refractory - GERD Mechanisms in Systemic Sclerosis
NCT07022912 ·Status: NOT_YET_RECRUITING
-
Endoscopic Resection in Gastro-Esophageal Reflux Disease
NCT03357809 ·Status: SUSPENDED ·Phase: NA
-
Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD
NCT00634023 ·Status: COMPLETED
-
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
NCT00336219 ·Status: COMPLETED ·Phase: PHASE3
-
Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)
NCT03228407 ·Status: UNKNOWN ·Phase: NA
-
[Impedance Measurement for Non-Erosive Reflux Disease
NCT02997527 ·Status: WITHDRAWN ·Phase: NA
-
Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)
NCT02039869 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572 ·Status: RECRUITING
-
Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy
NCT01874535 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms Preventing Pharyngeal Reflux
NCT05696184 ·Status: RECRUITING ·Phase: NA
-
Detection of Minimal Change Esophagitis by I-scan
NCT01560910 ·Status: COMPLETED
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease
NCT03883074 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA